These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 20961657)
1. The economic costs to United States hospitals of invasive fungal infections in transplant patients. Menzin J; Meyers JL; Friedman M; Korn JR; Perfect JR; Langston AA; Danna RP; Papadopoulos G Am J Infect Control; 2011 May; 39(4):e15-20. PubMed ID: 20961657 [TBL] [Abstract][Full Text] [Related]
2. Prospective surveillance for invasive fungal infections in hematopoietic stem cell transplant recipients, 2001-2006: overview of the Transplant-Associated Infection Surveillance Network (TRANSNET) Database. Kontoyiannis DP; Marr KA; Park BJ; Alexander BD; Anaissie EJ; Walsh TJ; Ito J; Andes DR; Baddley JW; Brown JM; Brumble LM; Freifeld AG; Hadley S; Herwaldt LA; Kauffman CA; Knapp K; Lyon GM; Morrison VA; Papanicolaou G; Patterson TF; Perl TM; Schuster MG; Walker R; Wannemuehler KA; Wingard JR; Chiller TM; Pappas PG Clin Infect Dis; 2010 Apr; 50(8):1091-100. PubMed ID: 20218877 [TBL] [Abstract][Full Text] [Related]
3. Invasive fungal infections among organ transplant recipients: results of the Transplant-Associated Infection Surveillance Network (TRANSNET). Pappas PG; Alexander BD; Andes DR; Hadley S; Kauffman CA; Freifeld A; Anaissie EJ; Brumble LM; Herwaldt L; Ito J; Kontoyiannis DP; Lyon GM; Marr KA; Morrison VA; Park BJ; Patterson TF; Perl TM; Oster RA; Schuster MG; Walker R; Walsh TJ; Wannemuehler KA; Chiller TM Clin Infect Dis; 2010 Apr; 50(8):1101-11. PubMed ID: 20218876 [TBL] [Abstract][Full Text] [Related]
4. Epidemiology and outcome of invasive fungal infections in solid organ transplant recipients. Neofytos D; Fishman JA; Horn D; Anaissie E; Chang CH; Olyaei A; Pfaller M; Steinbach WJ; Webster KM; Marr KA Transpl Infect Dis; 2010 Jun; 12(3):220-9. PubMed ID: 20113459 [TBL] [Abstract][Full Text] [Related]
5. Epidemiology of paediatric invasive fungal infections and a case-control study of risk factors in acute leukaemia or post stem cell transplant. Hale KA; Shaw PJ; Dalla-Pozza L; MacIntyre CR; Isaacs D; Sorrell TC Br J Haematol; 2010 Apr; 149(2):263-72. PubMed ID: 20096013 [TBL] [Abstract][Full Text] [Related]
6. Addition of aerosolized deoxycholate amphotericin B to systemic prophylaxis to prevent airways invasive fungal infections in allogeneic hematopoietic SCT: a single-center retrospective study. Morello E; Pagani L; Coser P; Cavattoni I; Cortelazzo S; Casini M; Billio A; Rossi G Bone Marrow Transplant; 2011 Jan; 46(1):132-6. PubMed ID: 20383205 [TBL] [Abstract][Full Text] [Related]
7. Fungal infections in hematopoietic stem cell transplantation and solid-organ transplantation--focus on aspergillosis. Nucci M; Anaissie E Clin Chest Med; 2009 Jun; 30(2):295-306, vii. PubMed ID: 19375636 [TBL] [Abstract][Full Text] [Related]
8. Longitudinal study of bacterial, viral, and fungal infections in adult recipients of bone marrow transplants. Ninin E; Milpied N; Moreau P; André-Richet B; Morineau N; Mahé B; Vigier M; Imbert BM; Morin O; Harousseau JL; Richet H Clin Infect Dis; 2001 Jul; 33(1):41-7. PubMed ID: 11389493 [TBL] [Abstract][Full Text] [Related]
9. Fungal infections in recipients of hematopoietic stem cell transplants: results of the SEIFEM B-2004 study--Sorveglianza Epidemiologica Infezioni Fungine Nelle Emopatie Maligne. Pagano L; Caira M; Nosari A; Van Lint MT; Candoni A; Offidani M; Aloisi T; Irrera G; Bonini A; Picardi M; Caramatti C; Invernizzi R; Mattei D; Melillo L; de Waure C; Reddiconto G; Fianchi L; Valentini CG; Girmenia C; Leone G; Aversa F Clin Infect Dis; 2007 Nov; 45(9):1161-70. PubMed ID: 17918077 [TBL] [Abstract][Full Text] [Related]
10. Incidence of fungal infections in a solid organ recipients dedicated intensive care unit. Pugliese F; Ruberto F; Cappannoli A; Perrella SM; Bruno K; Martelli S; Marcellino V; D'Alio A; Diso D; Rossi M; Corradini SG; Morabito V; Rolla M; Ferretti G; Venuta F; Berloco PB; Coloni GF; Pietropaoli P Transplant Proc; 2007; 39(6):2005-7. PubMed ID: 17692677 [TBL] [Abstract][Full Text] [Related]
11. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres. Sheng WH; Wang JT; Lu DC; Chie WC; Chen YC; Chang SC J Hosp Infect; 2005 Mar; 59(3):205-14. PubMed ID: 15694977 [TBL] [Abstract][Full Text] [Related]
12. Effect of prophylaxis on fungal infection and costs for high-risk liver transplant recipients. Reed A; Herndon JB; Ersoz N; Fujikawa T; Schain D; Lipori P; Hemming A; Li Q; Shenkman E; Vogel B Liver Transpl; 2007 Dec; 13(12):1743-50. PubMed ID: 18044769 [TBL] [Abstract][Full Text] [Related]
13. Excess mortality, length of stay, and costs associated with serious fungal infections among elderly cancer patients: findings from linked SEER-Medicare data. Menzin J; Lang KM; Friedman M; Dixon D; Marton JP; Wilson J Value Health; 2005; 8(2):140-8. PubMed ID: 15804322 [TBL] [Abstract][Full Text] [Related]
14. The economic burden of lung cancer and the associated costs of treatment failure in the United States. Kutikova L; Bowman L; Chang S; Long SR; Obasaju C; Crown WH Lung Cancer; 2005 Nov; 50(2):143-54. PubMed ID: 16112249 [TBL] [Abstract][Full Text] [Related]